01 8Zytiga
02 2Zytiga
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 2,470
2019 Revenue in Millions : 2,795
Growth (%) : -12
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 2,297
2020 Revenue in Millions : 2,470
Growth (%) : -7
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 1,770
2021 Revenue in Millions : 2,297
Growth (%) : -23
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 887
2022 Revenue in Millions : 1,770
Growth (%) : -50
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 31.70%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 2,237
2014 Revenue in Millions : 2,231
Growth (%) : 0%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 2,260
2015 Revenue in Millions : 2,231
Growth (%) : 1
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 2,505
2016 Revenue in Millions : 2,260
Growth (%) : 11
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 3,498
2017 Revenue in Millions : 2,505
Growth (%) : 40%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 2,795
2018 Revenue in Millions : 3,498
Growth (%) : -20
LOOKING FOR A SUPPLIER?